Associated Papers
Unmasking Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS): Diagnostic pitfalls of de novo mutations.
Zhu YY et al.
The Journal of Allergy and Clinical Immunology. in Practice, 2025
TNF Receptor-Associated Periodic Syndrome: An Analysis of a Slovakian Cohort of TRAPS Patients.
Slenker B et al.
Archives of Rheumatology, 2025
Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.
Terré A et al.
European Journal of Internal Medicine, 2024
Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome.
Assrawi E et al.
Rheumatology (oxford, England), 2022
Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
Delaleu J et al.
Rheumatology (oxford, England), 2021
Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
Cudrici C et al.
International Journal of Molecular Sciences, 2020
Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
Yasumura J et al.
Frontiers in Immunology, 2020
A 2-year-old Japanese girl with TNF receptor-associated periodic syndrome: A case report of the youngest diagnosed proband in Japan.
Yasumura J et al.
Modern Rheumatology, 2016
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry.
Lachmann HJ et al.
Annals of the Rheumatic Diseases, 2014
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in Japan: a review of the literature.
Washio M et al.
Modern Rheumatology, 2013
Select a paper to view details